Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based studyPeter N Taylor, Caroline Minassian, Anis Rehman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2014
ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasiaLucia Gagliardi, Andreas W Schreiber, Christopher N Hahn, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2020
Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptidesRavinder K Singh, Camille Malosse, Joanne Davies, et al.
BMJ Open|April 7, 2018
Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohortVassiliki Bravis, Akaal Kaur, Helen C Walkey, et al.
Diabetologia|June 9, 2018
Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetesWendy E Powell, Stephanie J Hanna, Claire N Hocter, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2021
Modified-Release Hydrocortisone in Congenital Adrenal HyperplasiaDeborah P Merke, Ashwini Mallappa, Wiebke Arlt, et al.
Gastroenterology|May 3, 2012
Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitisBruce E Sands, William J Sandborn, Tom J Creed, et al.
Archives of Disease in Childhood|June 26, 2024
General population screening for type 1 diabetes using islet autoantibodies at the preschool vaccination visit: a proof-of-concept study (the T1Early study)Claire Scudder, Julia Townson, Jane Bowen-Morris, et al.
Diabetes|February 13, 2024
Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 DiabetesEsther Latres, Carla J Greenbaum, Maria L Oyaski, et al.
Clinical Endocrinology|May 16, 2025
Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease ControlRichard John M Ross, Wiebke Arlt, Aude Brac de la Perriere, et al.
Pageof 19